Myeloid cell‐specific deletion of Ufl1 or ubiquitin‐fold modifier 1 (Ufm1) significantly alleviates inflammatory responses in LPS‐induced endotoxemia and alum‐induced peritonitis. Here, UFL1 is linked to serum lipopolysaccharide activity.